The global poultry diagnostics market is estimated to reach USD 495.3 Million by 2022 from USD 300.6 Million in 2017, at a CAGR of 10.5%. The majority of the demand for testing kits such as ELISA and PCR tests is driven by the increase in disease outbreaks in poultry, rising prevalence of zoonotic diseases, and growing demand for poultry-derived food products.

In addition, the diagnostic monitoring of bacterial avian disease on a regular basis in regions like Europe is further driving the overall growth of the market. Emerging regions such as Asia-Pacific offer an added potential due to the large livestock population in this region, growing demand of poultry-derived food products, and increasing awareness about animal health.

Target Audience:

# Veterinary diagnostics manufacturers
# Veterinary diagnostics distributors
# Animal health research and development (R&D;) companies
# Veterinary reference laboratories
# Government associations
# Market research and consulting firms
# Venture capitalists and investors

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134560458

In this report, the poultry diagnostics market is segmented on the basis of product, service, and region.

On the basis of product, the market has been further segmented by test type and disease type. The test type segment accounted for the largest share of the market in 2016. It is also expected to grow at the highest CAGR during the forecast period. This can be attributed to the wide use of ELISA tests for preliminary screening of all avian diseases coupled with their high sensitivity, specificity, and cost-effective nature.

These tests are the most preferred for fast and accurate results. The disease type is also expected to register the fastest growth in the market during the forecast period. This is due to the recent surge in avian influenza outbreaks in countries like the U.S., Canada, and China. This has led to the adoption of various test kits to detect and combat its spread.

Geographical Growth:

Geographically, the global market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. In 2016, North America commanded a major share of the poultry diagnostics market. The large share can be attributed to increasing adoption of diagnostic modalities owing to the increasing number of avian disease outbreaks in the region, the rising veterinary healthcare expenditure in the region, and the growing government focus on improving food-producing animal health.

However, Asia-Pacific is expected to witness the highest growth during the forecast period. Growth in the Asia-Pacific market can be mainly due to the large livestock population in this region, growing demand of poultry-derived food products, increasing awareness about animal health, and growing per capita animal health expenditure, especially in India and China. Moreover, the increasing outbreak of avian influenza and Newcastle disease in this region is aiding the market growth.

Key Players:

The market is characterized by a large number of players. It is consolidated in nature and is dominated by IDEXX Laboratories, Inc. (U.S.), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc. (U.S.), Zoetis, Inc. (U.S.), GD Animal Health (Netherlands), IDvet (France), AffiniTech, LTD. (U.S.), AgroBioTek Internacional (Honduras), BioNote, Inc. (South Korea), BioChek (Netherlands), Boehringer Ingelheim (Germany), MEGACOR Diagnostik GmbH (Germany), and BioinGentech Biotechnologies, Inc. (Chile).

Different Growth Strategies Adopted:

Key players in the market are pursuing several organic and inorganic growth strategies such as product launches, expansions, collaborations, and acquisitions to garner larger shares in the market. During 2012 to 2017, companies adopted product launches as their major growth strategy followed by expansions.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=134560458

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]